This Week in European HealthTech and MedTech: 12th December 2025

European HealthTech this week is dominated by EU-level moves to unlock health data for AI, ongoing NHS digital transformation in the UK, and continued momentum around EU‑wide digital health initiatives and summits.​

EU data and AI rulebook

The European Commission’s proposed “Digital Omnibus” package includes a “Data Unlock” concept, adjusting GDPR and related digital laws to enable broader secondary use of health data for AI training under strict safeguards. This is paired with a wider “Digital Fitness Check” and timelines that link future high‑risk AI health applications to availability of harmonised standards, with long‑stop dates into 2027–2028 for full compliance.​

EU digital health strategy and events

The European Digital Health Summit in Madrid (1–2 December) focused on the European Health Data Space, cross‑border EHR interoperability and a “One Health” approach, highlighting that governance and access rules, rather than technology, are now the key bottlenecks. Fresh Commission communication this week also underlines that all EU countries now provide electronic health record access and are investing in e‑prescriptions, AI integration and digital governance as levers for productivity and resilience.​

NHS and UK digital initiatives

In the UK, a new reference guide from NHS Confed and national digital programmes detail up to £10 billion in committed NHS tech and digital transformation spend by 2028/29, with priorities around the NHS App, virtual wards, AI infrastructure and standardised use of wearables. The wider UK digital health strategy emphasises the NHS App as the “front door” to services, integration of consumer wearables into a single patient record, and expansion of AI‑powered tools for advice, triage and service comparison.​

Care, productivity and social care digitisation

The UK government reported that four in five care providers now use digital social care records, covering nearly 90% of people drawing on care, and framed this as a key driver of administrative time savings and better data sharing with NHS services. Independent analysis of NHS productivity this month links digital tools, including electronic records and decision‑support, to the system’s ambition of 2% annual productivity growth in the medium term.​

Ecosystem signals and funding

Weekly European startup funding round‑ups continue to show steady but selective capital deployment into verticalised AI and digital health infrastructure, with HealthTech deals featuring among broader tech raises across the continent. EU‑funded initiatives such as EDiHTA are being showcased in Commission‑backed webinars to demonstrate how projects support digital health transformation and to feed recommendations into future EU policy and reimbursement frameworks.

>>>

European MedTech this week is defined by three themes: regulatory moves around data and devices, imaging and diagnostics innovation (largely via RSNA spillover), and fresh capital forming for growth-stage and infrastructure-heavy plays in Europe.​

Regulation and policy

The European Commission’s emerging “Digital Omnibus” package includes a proposed “Data Unlock” that would ease the secondary use of health data for AI training under GDPR, with significant implications for MedTech and imaging AI developers.​

The Commission also published updated material on medical device availability monitoring and implementation of MDR/IVDR, signalling continued pressure on supply, data collection on market gaps, and further tweaks to the device rulebook through 2025–2026.​

Imaging, AI and platforms

At RSNA 2025, European majors such as Siemens Healthineers and Philips pushed next‑generation MRI and CT platforms emphasising energy efficiency and deeply embedded AI (for example, AI‑native spectral CT and interventional MRI workflows), reinforcing Europe’s strength in high-end imaging hardware plus software.​

GE HealthCare’s roughly 2.3 billion dollar acquisition of imaging IT vendor Intelerad, while US‑led, is highly relevant for European providers because it consolidates PACS/VNA and advanced imaging software into a tighter GE ecosystem that will compete more directly with incumbents like Agfa and Sectra across EU hospitals.​

Capital flows and M&A

Angelini Ventures and the European Investment Bank formally committed a 150 million euro co‑investment vehicle (75 million euros each) aimed at European biotech and MedTech scale‑ups, explicitly targeting the Series B “valley of death” that often pushes founders toward US buyers.​
Broader MedTech M&A commentary for 2025 highlights continued strategic consolidation in areas such as ophthalmology clinics and robotics, with Europe remaining a core geography for clinic networks and surgical technology platforms seeking scale and integrated care models.​

Events and ecosystem signals

MedTech Europe is preparing its annual value‑based procurement conference in Brussels (9 December), keeping reimbursement, outcomes-based contracting, and hospital procurement reform high on the agenda for device manufacturers selling into EU health systems.